Vistin Pharma Logo

Vistin Pharma

VISTN | OL

Overview

Corporate Details

ISIN(s):
NO0010734122
LEI:
5967007LIEEXZXFQY092
Country:
Norway
Address:
Postboks 6735 Etterstad, 0609 Oslo
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Vistin Pharma is a pharmaceutical company specializing in the production of Active Pharmaceutical Ingredients (APIs). The company is a leading global producer and a dedicated European manufacturer of Metformin, the standard first-line treatment for Type 2 diabetes. Vistin Pharma focuses on high-quality, sustainable production, supplying Metformin Hydrochloride in both standard and Direct Compressible (DC) grades to leading international pharmaceutical companies. It serves a significant portion of the global demand for this essential medicine.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Vistin Pharma. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-15 08:00
Interim Report
Vistin Pharma ASA: Second quarter and YTD 2025 financial results - Attachment: …
English 1.6 MB
2025-08-15 08:00
Investor Presentation
Vistin Pharma ASA: Second quarter and YTD 2025 financial results - Attachment: …
English 1.9 MB
2025-08-15 08:00
Earnings Release
Vistin Pharma ASA: Second quarter and YTD 2025 financial results
English 2.1 KB
2025-08-08 10:00
Regulatory News Service
Vistin Pharma ASA: Invitation to Q2 2025 conference call
English 1.6 KB
2025-06-04 08:00
Notice of Dividend Amount
Ex dividend NOK 1.25 today
English 330 bytes
2025-05-23 09:22
Report Publication Announcement
Financial calendar
English 464 bytes
2025-05-23 09:22
Report Publication Announcement
Finansiell kalender
Norwegian 448 bytes
2025-05-22 12:59
Post-Annual General Meeting Information
Vistin Pharma ASA: Minutes from the annual general meeting 2025
English 897.7 KB
2025-05-22 12:59
Post-Annual General Meeting Information
Vistin Pharma ASA: Minutes from the annual general meeting 2025
English 736 bytes
2025-05-22 09:56
Proxy Solicitation & Information Statement
Disclosure of voting rights at AGM in Vistin Pharma ASA
English 963 bytes
2025-05-07 13:30
Board/Management Information
Vistin Pharma ASA (VISTN): Update from the Election Committee
English 1.3 KB
2025-05-06 13:03
Director's Dealing
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of la…
English 168.6 KB
2025-05-06 13:03
Director's Dealing
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of la…
English 172.1 KB
2025-05-06 13:03
Director's Dealing
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of la…
English 217.6 KB
2025-05-06 13:03
Major Shareholding Notification
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of la…
English 1.6 KB

Automate Your Workflow. Get a real-time feed of all Vistin Pharma filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Vistin Pharma via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK